Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms (Q37901360)

25 August 2017

1 reference

title

Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms (English)

1 reference

25 August 2017

1 reference

1 reference

1 reference

1 reference

1

1 reference

https://s100.copyright.com/AppDispatchServlet?title=Immunity%20to%20dengue%20virus%3A%20a%20tale%20of%20original%20antigenic%20sin%20and%20tropical%20cytokine%20storms&author=Alan%20L.%20Rothman&contentID=10.1038%2Fnri3014&copyright=Nature%20Publishing%20Group%2C%20a%20division%20of%20Macmillan%20Publishers%20Limited.%20All%20Rights%20Reserved.&publication=1474-1733&publicationDate=2011-07-15&publisherName=SpringerNature&orderBeanReset=true

25 August 2017

1 reference

language of work or name

1 reference

15 July 2011

1 reference

Nature Reviews Immunology

25 August 2017

1 reference

25 August 2017

11

1 reference

25 August 2017

8

1 reference

25 August 2017

532-543

1 reference

https://s100.copyright.com/AppDispatchServlet?title=Immunity%20to%20dengue%20virus%3A%20a%20tale%20of%20original%20antigenic%20sin%20and%20tropical%20cytokine%20storms&author=Alan%20L.%20Rothman&contentID=10.1038%2Fnri3014&copyright=Nature%20Publishing%20Group%2C%20a%20division%20of%20Macmillan%20Publishers%20Limited.%20All%20Rights%20Reserved.&publication=1474-1733&publicationDate=2011-07-15&publisherName=SpringerNature&orderBeanReset=true

25 August 2017

1 reference

exact match

https://scigraph.springernature.com/pub.10.1038/nri3014

0 references

cites work

Localization of dengue virus in naturally infected human tissues, by immunohistochemistry and in situ hybridization

1 reference

Phenotyping of peripheral blood mononuclear cells during acute dengue illness demonstrates infection and increased activation of monocytes in severe cases compared to classic dengue fever

31 March 2020

1 reference

Research on dengue during World War II

31 March 2020

1 reference

A prospective study of dengue infections in Bangkok

31 March 2020

1 reference

Risk factors in dengue shock syndrome.

31 March 2020

1 reference

A prospective seroepidemiologic study on dengue in children four to nine years of age in Yogyakarta, Indonesia I. studies in 1995-1996.

31 March 2020

1 reference

Dengue and chikungunya virus infection in man in Thailand, 1962-1964. IV. Epidemiologic studies in the Bangkok metropolitan area

31 March 2020

1 reference

A Prospective Nested Case-Control Study of Dengue in Infants: Rethinking and Refining the Antibody-Dependent Enhancement Dengue Hemorrhagic Fever Model

31 March 2020

1 reference

Evolutionary relationships of endemic/epidemic and sylvatic dengue viruses

31 March 2020

1 reference

Mouse models of dengue virus infection and disease

31 March 2020

1 reference

Dengue Fever in Humanized NOD/SCID Mice

31 March 2020

1 reference

Dengue virus infection and virus-specific HLA-A2 restricted immune responses in humanized NOD-scid IL2rgammanull mice

31 March 2020

1 reference

Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica

31 March 2020

1 reference

Structure and function analysis of therapeutic monoclonal antibodies against dengue virus type 2.

31 March 2020

1 reference

West Nile virus in complex with the Fab fragment of a neutralizing monoclonal antibody

31 March 2020

1 reference

Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteins

31 March 2020

1 reference

Structural basis for the preferential recognition of immature flaviviruses by a fusion-loop antibody

31 March 2020

1 reference

Antibodies to Envelope Glycoprotein of Dengue Virus during the Natural Course of Infection Are Predominantly Cross-Reactive and Recognize Epitopes Containing Highly Conserved Residues at the Fusion Loop of Domain II

31 March 2020

1 reference

Neutralizing and non-neutralizing monoclonal antibodies against dengue virus E protein derived from a naturally infected patient

31 March 2020

1 reference

The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity

31 March 2020

1 reference

Dengue virus neutralization by human immune sera: Role of envelope protein domain III-reactive antibody

31 March 2020

1 reference

Structure of dengue virus: implications for flavivirus organization, maturation, and fusion

31 March 2020

1 reference

Cross-reacting antibodies enhance dengue virus infection in humans

31 March 2020

1 reference

High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever

31 March 2020

1 reference

Structural basis of West Nile virus neutralization by a therapeutic antibody

31 March 2020

1 reference

Human Monoclonal Antibodies against West Nile Virus Induced by Natural Infection Neutralize at a Postattachment Step

31 March 2020

1 reference

The Stoichiometry of Antibody-Mediated Neutralization and Enhancement of West Nile Virus Infection

31 March 2020

1 reference

Dengue Plaque Reduction Neutralization Test (PRNT) in Primary and Secondary Dengue Virus Infections: How Alterations in Assay Conditions Impact Performance

31 March 2020

1 reference

Mechanisms of immune evasion induced by a complex of dengue virus and preexisting enhancing antibodies

31 March 2020

1 reference

Cell type specificity and host genetic polymorphisms influence antibody-dependent enhancement of dengue virus infection

31 March 2020

1 reference

Complement Protein C1q Inhibits Antibody-Dependent Enhancement of Flavivirus Infection in an IgG Subclass-Specific Manner

31 March 2020

1 reference

Protection of mice against dengue 2 virus encephalitis by immunization with the dengue 2 virus non-structural glycoprotein NS1.

31 March 2020

1 reference

Antibodies from patients with dengue viral infection mediate cellular cytotoxicity

31 March 2020

1 reference

Antibody-dependent cellular cytotoxicity mediated by plasma obtained before secondary dengue virus infections: potential involvement in early control of viral replication.

31 March 2020

1 reference

Meta-analysis of all immune epitope data in the Flavivirus genus: inventory of current immune epitope data status in the context of virus immunity and immunopathology

31 March 2020

1 reference

Immunodominant T-cell responses to dengue virus NS3 are associated with DHF.

31 March 2020

1 reference

Altered cytokine responses of dengue-specific CD4+ T cells to heterologous serotypes

31 March 2020

1 reference

Dengue virus-reactive CD8+ T cells display quantitative and qualitative differences in their response to variant epitopes of heterologous viral serotypes

31 March 2020

1 reference

Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever

31 March 2020

1 reference

Differential Functional Avidity of Dengue Virus-Specific T-Cell Clones for Variant Peptides Representing Heterologous and Previously Encountered Serotypes

31 March 2020

1 reference

Dengue virus-specific human T cell clones. Serotype crossreactive proliferation, interferon gamma production, and cytotoxic activity

31 March 2020

1 reference

High Pro-Inflammatory Cytokine Secretion and Loss of High Avidity Cross-Reactive Cytotoxic T-Cells during the Course of Secondary Dengue Virus Infection

31 March 2020

1 reference

Memory CD8+ T cells from naturally acquired primary dengue virus infection are highly cross-reactive

31 March 2020

1 reference

Discrimination between Primary and Secondary Dengue Virus Infection by an Immunoglobulin G Avidity Test Using a Single Acute-Phase Serum Sample

31 March 2020

1 reference

Inferring the serotype associated with dengue virus infections on the basis of pre- and postinfection neutralizing antibody titers

31 March 2020

1 reference

An in-depth analysis of original antigenic sin in dengue virus infection

31 March 2020

1 reference

Human T cell responses to dengue virus antigens. Proliferative responses and interferon gamma production

31 March 2020

1 reference

Monoclonal antibodies for dengue virus prM glycoprotein protect mice against lethal dengue infection.

31 March 2020

1 reference

Genotype-specific neutralization and protection by antibodies against dengue virus type 3.

31 March 2020

1 reference

Epitope Determinants of a Chimpanzee Dengue Virus Type 4 (DENV-4)-Neutralizing Antibody and Protection against DENV-4 Challenge in Mice and Rhesus Monkeys by Passively Transferred Humanized Antibody

31 March 2020

1 reference

Synergistic Interactions of Anti-NS1 Monoclonal Antibodies Protect Passively Immunized Mice from Lethal Challenge with Dengue 2 Virus

31 March 2020

1 reference

Relationship of preexisting dengue virus (DV) neutralizing antibody levels to viremia and severity of disease in a prospective cohort study of DV infection in Thailand

31 March 2020

1 reference

Dengue-specific CD8+ T cells have both protective and pathogenic roles in dengue virus infection

31 March 2020

1 reference

A Protective Role for Dengue Virus-Specific CD8+ T Cells

31 March 2020

1 reference

Recombinant nucleocapsid-like particles from dengue-2 virus induce protective CD4+ and CD8+ cells against viral encephalitis in mice

31 March 2020

1 reference

Nucleocapsid-like particles of dengue-2 virus enhance the immune response against a recombinant protein of dengue-4 virus.

31 March 2020

1 reference

Dengue-specific T cell responses in peripheral blood mononuclear cells obtained prior to secondary dengue virus infections in Thai schoolchildren

31 March 2020

1 reference

Intracellular cytokine production by dengue virus-specific T cells correlates with subclinical secondary infection

31 March 2020

1 reference

A human challenge model for dengue infection reveals a possible protective role for sustained interferon gamma levels during the acute phase of illness

31 March 2020

1 reference

Monoclonal antibody-mediated enhancement of dengue virus infection in vitro and in vivo and strategies for prevention

31 March 2020

1 reference

Enhanced Infection of Liver Sinusoidal Endothelial Cells in a Mouse Model of Antibody-Induced Severe Dengue Disease

31 March 2020

1 reference

Antibody-enhanced infection of monocytes as the pathogenetic mechanism for severe dengue illness

31 March 2020

1 reference

Dengue Virus (DV) enhancing antibody activity in preillness plasma does not predict subsequent disease severity or viremia in secondary DV infection

31 March 2020

1 reference

Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity

31 March 2020

1 reference

Dengue in the early febrile phase: viremia and antibody responses

31 March 2020

1 reference

Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections

31 March 2020

1 reference

Vascular leakage in severe dengue virus infections: a potential role for the nonstructural viral protein NS1 and complement

31 March 2020

1 reference

Development of Cross-Reactive Antibodies to Plasminogen during the Immune Response to Dengue Virus Infection

31 March 2020

1 reference

The dengue virus nonstructural-1 protein (NS1) generates antibodies to common epitopes on human blood clotting, integrin/adhesin proteins and binds to human endothelial cells: potential implications in haemorrhagic fever pathogenesis

31 March 2020

1 reference

Kidney cancer: the Cytokine Working Group experience (1986-2001): part II. Management of IL-2 toxicity and studies with other cytokines

31 March 2020

1 reference

The Dual Role of TNF in Pulmonary Edema

31 March 2020

1 reference

Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue

31 March 2020

1 reference

Early Immune Activation in Acute Dengue Illness Is Related to Development of Plasma Leakage and Disease Severity

31 March 2020

1 reference

Early CD69 expression on peripheral blood lymphocytes from children with dengue hemorrhagic fever

31 March 2020

1 reference

Dengue in Vietnamese Infants—Results of Infection‐Enhancement Assays Correlate with Age‐Related Disease Epidemiology, and Cellular Immune Responses Correlate with Disease Severity

31 March 2020

1 reference

Elevated plasma interleukin-10 levels in acute dengue correlate with disease severity

31 March 2020

1 reference

Histocompatibility Antigens and Dengue Hemorrhagic Fever *

31 March 2020

1 reference

HLA-A and -B allele associations with secondary dengue virus infections correlate with disease severity and the infecting viral serotype in ethnic Thais.

31 March 2020

1 reference

Strong HLA class I--restricted T cell responses in dengue hemorrhagic fever: a double-edged sword?

31 March 2020

1 reference

Phase 2 clinical trial of three formulations of tetravalent live-attenuated dengue vaccine in flavivirus-naïve adults

31 March 2020

1 reference

Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteers

31 March 2020

1 reference

Induction of T lymphocyte responses to dengue virus by a candidate tetravalent live attenuated dengue virus vaccine

31 March 2020

1 reference

Viremia and immunogenicity in nonhuman primates of a tetravalent yellow fever-dengue chimeric vaccine: genetic reconstructions, dose adjustment, and antibody responses against wild-type dengue virus isolates

31 March 2020

1 reference

A novel tetravalent dengue vaccine is well tolerated and immunogenic against all 4 serotypes in flavivirus-naive adults

31 March 2020

1 reference

Cell-mediated immunity induced by chimeric tetravalent dengue vaccine in naive or flavivirus-primed subjects

31 March 2020

1 reference

Development of a live attenuated dengue virus vaccine using reverse genetics

31 March 2020

1 reference

Dengue 2 PDK-53 Virus as a Chimeric Carrier for Tetravalent Dengue Vaccine Development

31 March 2020

1 reference

Interferon-dependent immunity is essential for resistance to primary dengue virus infection in mice, whereas T- and B-cell-dependent immunity are less critical

31 March 2020

1 reference

Both Virus and Tumor Necrosis Factor Alpha Are Critical for Endothelium Damage in a Mouse Model of Dengue Virus-Induced Hemorrhage

31 March 2020

1 reference

Essential role of platelet-activating factor receptor in the pathogenesis of Dengue virus infection

31 March 2020

1 reference

Manifestation of thrombocytopenia in dengue-2-virus-infected mice

31 March 2020

1 reference

Murine Model for Dengue Virus-Induced Lethal Disease with Increased Vascular Permeability

31 March 2020

1 reference

Efficacy of a live attenuated tetravalent candidate dengue vaccine in naïve and previously infected cynomolgus macaques.

31 March 2020

1 reference

Safety and efficacy of chimeric yellow Fever-dengue virus tetravalent vaccine formulations in nonhuman primates

31 March 2020

1 reference

Locally acquired Dengue--Key West, Florida, 2009-2010.

31 March 2020

1 reference

12 December 2020

Serotype-specific T(H)1 responses in recipients of two doses of candidate live-attenuated dengue virus vaccines

1 reference

12 December 2020

Original antigenic sin in dengue

1 reference

12 December 2020

HLA and other gene associations with dengue disease severity

1 reference

12 December 2020

Evidence That Maternal Dengue Antibodies Are Important in the Development of Dengue Hemorrhagic Fever in Infants

1 reference

12 December 2020

Antibodies against dengue viral proteins in primary and secondary dengue hemorrhagic fever

1 reference

12 December 2020

Predominance of HLA-restricted cytotoxic T-lymphocyte responses to serotype-cross-reactive epitopes on nonstructural proteins following natural secondary dengue virus infection

1 reference

12 December 2020

Dengue virus-specific cross-reactive CD8+ human cytotoxic T lymphocytes

1 reference

12 December 2020

Human Dengue antibodies against structural and nonstructural proteins

1 reference

12 December 2020

Markers of dengue disease severity

1 reference

12 December 2020

Partial agonist effect influences the CTL response to a heterologous dengue virus serotype.

1 reference

12 December 2020

Monoclonal antibodies against dengue 2 virus E-glycoprotein protect mice against lethal dengue infection

1 reference

12 December 2020

Complement and dengue haemorrhagic fever/shock syndrome.

1 reference

12 December 2020

Differential in vivo clearance and response to secondary heterologous infections by H2(b)-restricted dengue virus-specific CD8+ T cells

1 reference

12 December 2020

Proteolytic activation of tick-borne encephalitis virus by furin

1 reference

12 December 2020

An antigen capture enzyme-linked immunosorbent assay reveals high levels of the dengue virus protein NS1 in the sera of infected patients

1 reference

12 December 2020

New mouse model for dengue virus vaccine testing

1 reference

12 December 2020

Dengue virus nonstructural protein 1 is expressed in a glycosyl-phosphatidylinositol-linked form that is capable of signal transduction

1 reference

12 December 2020

Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever

1 reference

12 December 2020

First two autochthonous dengue virus infections in metropolitan France, September 2010.

1 reference

12 December 2020

Elevated plasma interleukin-10 levels in acute dengue correlate with disease severity

1 reference

12 December 2020

Murine immunoglobulin G subclass responses following immunization with live dengue virus or a recombinant dengue envelope protein

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRI3014

1 reference

PubMed ID

21760609

Dimensions Publication ID

25 August 2017

1022630717

0 references

Fatcat ID

release_g7gmnlajbrfjxhllbktr4a6a4a

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/g7gmnlajbrfjxhllbktr4a6a4a

24 November 2022

mapped directly with Wikidata item

PubMed ID

21760609

1 reference

PubMed ID

21760609